var data={"title":"Dermoscopic algorithms for skin cancer triage","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Dermoscopic algorithms for skin cancer triage</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/contributors\" class=\"contributor contributor_credentials\">Natalia Jaimes, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/contributors\" class=\"contributor contributor_credentials\">Ashfaq A Marghoob, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/contributors\" class=\"contributor contributor_credentials\">Hensin Tsao, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 24, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1060806022\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dermoscopy is a noninvasive, in vivo technique used for the evaluation of skin lesions. It allows for the visualization of subsurface skin structures in the epidermis, dermoepidermal junction, and upper dermis, which are otherwise not visible to the naked eye [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/1-3\" class=\"abstract_t\">1-3</a>].</p><p>Numerous clinical trials and meta-analyses of studies performed in experimental and clinical settings have demonstrated that dermoscopy increases the sensitivity for the diagnosis of melanoma compared with naked-eye examination [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/4-8\" class=\"abstract_t\">4-8</a>]. However, in general dermatology and primary care practices the main purpose of dermoscopy in the evaluation of pigmented and nonpigmented skin lesions is to help the clinician decide whether or not to perform a skin biopsy, refer to an expert, reassure the patient, or monitor the lesion over time with sequential digital dermoscopy imaging to determine its biologic nature [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Triage refers to the sorting out and classification of patients and lesions to determine priority of need and proper place of treatment [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/9\" class=\"abstract_t\">9</a>]. In the setting of skin cancer triage, dermoscopy is an important tool that helps identify lesions for which malignancy needs to be ruled out. In the triage setting, a correct management decision (eg, to biopsy or not) is paramount, whereas making a specific diagnosis is less important. For the purpose of deciding which lesion(s) should be biopsied, several simplified algorithms have been proposed for use in a skin cancer triage setting [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/10-13\" class=\"abstract_t\">10-13</a>].</p><p>This topic will review several dermoscopic algorithms for pigmented and nonpigmented lesions (<a href=\"image.htm?imageKey=DERM%2F101922\" class=\"graphic graphic_table graphicRef101922 \">table 1</a>). The principles of dermoscopy and dermoscopic evaluation of skin, mucosal, and nail lesions are discussed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-dermoscopy\" class=\"medical medical_review\">&quot;Overview of dermoscopy&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=dermoscopic-evaluation-of-skin-lesions\" class=\"medical medical_review\">&quot;Dermoscopic evaluation of skin lesions&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=dermoscopy-of-pigmented-lesions-of-the-palms-and-soles\" class=\"medical medical_review\">&quot;Dermoscopy of pigmented lesions of the palms and soles&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=dermoscopy-of-facial-lesions\" class=\"medical medical_review\">&quot;Dermoscopy of facial lesions&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=dermoscopy-of-mucosal-lesions\" class=\"medical medical_review\">&quot;Dermoscopy of mucosal lesions&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=dermoscopy-of-nail-pigmentations\" class=\"medical medical_review\">&quot;Dermoscopy of nail pigmentations&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1060806028\"><span class=\"h1\">DERMOSCOPY TECHNIQUES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dermoscopy can be performed by using a contact or noncontact mode and a polarized or nonpolarized light source; the combinations result in three dermoscopic techniques that allow the visualization of skin structures that are not visible to the naked eye:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Contact dermoscopy with nonpolarized light &ndash; Contact dermoscopy using nonpolarized light (classic dermoscopy) requires direct contact between the scope lens and the skin surface with a liquid interface (eg, ultrasound gel, 70% ethanol).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Contact dermoscopy with polarized light &ndash; Contact dermoscopy using polarized light does not require a liquid interface. However, a liquid interface can be used for contact dermoscopy using polarized light to achieve a clearer image.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noncontact dermoscopy &ndash; Noncontact dermoscopy can only be performed with polarized light.</p><p/><p>The contact modes provide increased illumination and clarity of the image compared with noncontact dermoscopy [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/1\" class=\"abstract_t\">1</a>]. Polarized light allows for visualization of the deeper skin layers, and therefore colors (pink, red, and white) (<a href=\"image.htm?imageKey=DERM%2F71482\" class=\"graphic graphic_figure graphicRef71482 \">figure 1</a>) and structures, including white scar-like areas, shiny white structures (eg, shiny white lines, rosettes, shiny white blotches and strands) (<a href=\"image.htm?imageKey=DERM%2F77673%7EDERM%2F63870%7EDERM%2F74019\" class=\"graphic graphic_figure graphicRef77673 graphicRef63870 graphicRef74019 \">figure 2A-C</a>), and vascular structures (<a href=\"image.htm?imageKey=DERM%2F79290%7EDERM%2F56826\" class=\"graphic graphic_table graphicRef79290 graphicRef56826 \">table 2A-B</a>), are more conspicuous with polarized dermoscopy [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/14-16\" class=\"abstract_t\">14-16</a>]. Since these structures are important for the identification of skin cancer, the use of polarized dermoscopy is preferred for skin cancer screening [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/14\" class=\"abstract_t\">14</a>].</p><p class=\"headingAnchor\" id=\"H1060806034\"><span class=\"h1\">ALGORITHMS FOR PIGMENTED LESIONS</span></p><p class=\"headingAnchor\" id=\"H1060806042\"><span class=\"h2\">The three-point checklist</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The three-point checklist was initially developed for nonexperts as a skin cancer screening tool with high sensitivity for pigmented skin cancer, including pigmented melanoma and pigmented basal cell carcinoma (BCC) (<a href=\"image.htm?imageKey=DERM%2F68025\" class=\"graphic graphic_table graphicRef68025 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/10,17\" class=\"abstract_t\">10,17</a>]. This method is based upon three dermoscopic criteria:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asymmetry of pattern and distribution of dermoscopic structures</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atypical network</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Blue-white structures</p><p/><p>The asymmetric distribution of colors and structures within a lesion is considered the best predictor of malignancy, followed by blue-white structures and atypical network [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/17\" class=\"abstract_t\">17</a>]. One point is assigned to each criterion present in the lesion. A total score of two points is considered positive and provides sufficient evidence to warrant a biopsy or referral to an expert.</p><p>The three-point checklist has a sensitivity of 79 to 91 percent and a specificity of 71 to 72 percent for the diagnosis of melanoma and BCC [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/4,17\" class=\"abstract_t\">4,17</a>]. It should be noted that the three-point checklist was designed to help identify lesions suspicious for melanoma or pigmented BCC that needed to be biopsied for histopathologic examination.</p><p>The three-point checklist was not designed nor tested for its ability to identify lesions suspicious for pigmented squamous cell carcinoma (SCC). Although pigmented SCC in situ (Bowen disease) often manifests dermoscopic asymmetry, white color in the form of rosettes (seen only with polarized light dermoscopy) and white circles, many pigmented SCCs reveal only dermoscopic asymmetry without blue-white color or atypical network and dots. To avoid missing a pigmented SCC when utilizing the three-point checklist, any pigmented lesion with focal adherent keratin or a rough texture that manifests an asymmetric dermoscopic pattern should be considered suspicious and biopsied (<a href=\"image.htm?imageKey=DERM%2F101930\" class=\"graphic graphic_picture graphicRef101930 \">picture 1</a>).</p><p class=\"headingAnchor\" id=\"H1060806048\"><span class=\"h3\">Limitations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The three-point checklist can only be applied in the evaluation of pigmented lesions. Thus, this algorithm will miss amelanotic or hypomelanotic skin cancers, including SCC. In addition, benign lesions revealing blue-white color (eg, seborrheic keratosis) or asymmetric distribution of bluish structures (eg, angioma, angiokeratoma) may be misclassified as suspicious and undergo unnecessary biopsy.</p><p class=\"headingAnchor\" id=\"H1060806054\"><span class=\"h2\">The AC rule</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The AC rule was developed as a simple rule to identify lesions suspicious for melanoma [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/11\" class=\"abstract_t\">11</a>]. This method is based on two dermoscopic criteria:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asymmetry in distribution of dermoscopic structures and colors</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Color variation; multiple colors within the lesion with black or blue-gray color being most suggestive of melanoma</p><p/><p>The AC Rule has been tested among laypersons, demonstrating a high sensitivity (93 percent) and acceptable specificity (64 percent) for melanoma. It was also tested by experienced clinicians, demonstrating a high sensitivity (87 percent) and specificity (92 percent) (<a href=\"image.htm?imageKey=DERM%2F101931\" class=\"graphic graphic_picture graphicRef101931 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/11,18\" class=\"abstract_t\">11,18</a>].</p><p class=\"headingAnchor\" id=\"H1060806060\"><span class=\"h3\">Limitations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The AC rule can only be used in the evaluation of pigmented lesions. In addition, benign lesions such as pigmented seborrheic keratoses and angiomas revealing an asymmetric distribution of structures may be misclassified as suspicious and subjected to biopsy.</p><p class=\"headingAnchor\" id=\"H1060806066\"><span class=\"h2\">The blue-black rule</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The &quot;blue-black rule&quot; was introduced as a means to identify pigmented nodular melanomas, which often appear as symmetric <span class=\"nowrap\">papules/nodules</span> [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/12\" class=\"abstract_t\">12</a>]. This rule is based on the presence of blue-black color, defined as the presence of a combination of blue and black color involving at least 10 percent of the lesion surface area.</p><p>In one study of 283 pigmented lesions (170 malignant), the presence of a blue-black color in a papule or nodule demonstrated a 78 percent sensitivity for melanoma [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/12\" class=\"abstract_t\">12</a>]. The sensitivity increased to up to 85 percent when the observers also looked for the classic melanoma-specific structures (ie, atypical network, negative network, irregular streaks, regression structures, and irregular brown structureless areas) (<a href=\"image.htm?imageKey=DERM%2F101932\" class=\"graphic graphic_figure graphicRef101932 \">figure 3</a>).</p><p>Specificity for melanoma was 81 percent when using the blue-black rule only, 98 percent when using the classic melanoma-specific structures only, and 81 percent when using both criteria (ie, blue-black rule and classic melanoma structures). In addition to detecting nodular melanoma, the presence of blue-black color can also aid in the detection of other heavily pigmented skin malignancies, including pigmented nodular BCCs (<a href=\"image.htm?imageKey=DERM%2F101934\" class=\"graphic graphic_picture graphicRef101934 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"headingAnchor\" id=\"H1060806072\"><span class=\"h3\">Limitations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The blue-black rule is not useful for the detection of skin cancers lacking blue or black color. Moreover, benign lesions showing blue-black color (ie, thrombosed angiomas, angiokeratoma, seborrheic keratosis) would be misclassified as suspicious and subjected to unnecessary biopsy.</p><p class=\"headingAnchor\" id=\"H1060806078\"><span class=\"h2\">Chaos and clues</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The &quot;chaos and clues&quot; algorithm was developed for the evaluation of pigmented skin lesions (<a href=\"image.htm?imageKey=DERM%2F101935\" class=\"graphic graphic_algorithm graphicRef101935 \">algorithm 1</a>) [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/13\" class=\"abstract_t\">13</a>]. Chaos and clues uses five basic geometric elements to describe dermoscopic structures:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lines</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pseudopods</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Circles</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clods (any well-circumscribed, solid structure of any shape)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dots</p><p/><p>Lines are further subclassified into five subtypes, namely reticular, branched, parallel, radial, and curved [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/13\" class=\"abstract_t\">13</a>]. Based upon this rule, any lesion manifesting dermoscopic chaos requires further in-depth dermoscopic analysis to determine whether it contains any specific clues for malignancy.</p><p><strong>Chaos</strong> is defined as the asymmetric distribution of dermoscopic structures or colors. While a pigmented cutaneous malignancy will almost always display chaos, there are lesions not displaying chaos for which malignancy should still be considered. Exceptions to the chaos rule include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any changing lesion in an adult patient</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any lesion on the head or neck showing gray color (even if present only focally)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any pigmented nodular lesion (see <a href=\"#H1060806066\" class=\"local\">'The blue-black rule'</a> above)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any acral volar lesion with a parallel ridge pattern</p><p/><p>Lesions that do not display chaos and do not conform to one of the four exceptions listed above are likely benign and can be monitored over time for change. In contrast, if chaos is present, the observer should evaluate the lesion for the presence of any of the following <strong>clues for malignancy</strong> (<a href=\"image.htm?imageKey=DERM%2F101936\" class=\"graphic graphic_table graphicRef101936 \">table 4</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eccentric structureless area of any color, except skin color</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thick lines, reticular or branched</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gray or blue structures (ie, lines, circles, clods and dots)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Black dots or clods, located in the periphery</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radial lines or pseudopods, segmental (or focal)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>White lines, including lines arranged perpendicularly to each other (only seen with polarized dermoscopy) and reticular white lines (seen with both polarized and nonpolarized dermoscopy)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Polymorphous vessels (more than one vessel morphology)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lines parallel, ridges (volar) or chaotic (nails)</p><p/><p>If <strong>any</strong> of these clues is present, the lesion should be biopsied and sent for histopathologic examination.</p><p>The chaos and clues algorithm has a sensitivity for any malignancy (ie, melanoma, BCC, SCC) of 91 percent and a specificity of 63 percent (<a href=\"image.htm?imageKey=DERM%2F101938\" class=\"graphic graphic_picture graphicRef101938 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/19\" class=\"abstract_t\">19</a>].</p><p class=\"headingAnchor\" id=\"H1060806090\"><span class=\"h3\">Limitations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The chaos and clues algorithm can only be used in the evaluation of pigmented lesions. It cannot assist in the detection of amelanotic or hypomelanotic skin cancers. In addition, skin cancers, including melanoma, manifesting a more symmetric starburst pattern may be misclassified as benign lesions.</p><p>Although searching for and identifying the clues to malignancy improves the sensitivity and specificity for detecting skin cancer, it does add a layer of complexity that makes this algorithm less than ideal to implement in a skin cancer triage setting.</p><p class=\"headingAnchor\" id=\"H1060806096\"><span class=\"h1\">ALGORITHMS FOR NONPIGMENTED LESIONS</span></p><p class=\"headingAnchor\" id=\"H1060806104\"><span class=\"h2\">Prediction without pigment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The &quot;prediction without pigment&quot; algorithm was created for the evaluation of amelanotic lesions, with the purpose of helping the clinician decide whether or not to perform a skin biopsy [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/20\" class=\"abstract_t\">20</a>]. This algorithm consists of three criteria that need to be evaluated in sequence (<a href=\"image.htm?imageKey=DERM%2F101940\" class=\"graphic graphic_algorithm graphicRef101940 \">algorithm 2</a> and <a href=\"image.htm?imageKey=DERM%2F101936\" class=\"graphic graphic_table graphicRef101936 \">table 4</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ulceration</strong> without a history of trauma: The presence of ulceration can be detected either clinically or dermoscopically.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>White clues </strong>(<a href=\"image.htm?imageKey=DERM%2F101941\" class=\"graphic graphic_picture graphicRef101941 \">picture 5</a>), including:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>White lines:</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Reticular white lines.</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Polarizing-specific white lines: This structure is usually seen in malignant lesions, in particular invasive melanomas. However, it may also be seen in other malignant lesions such as BCC.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Keratin clues (applicable only in the evaluation of palpable lesions), including:</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>White circles (associated with SCC).</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>White structureless areas, defined as structureless white zones.</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Surface keratin.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Vascular pattern</strong> (<a href=\"image.htm?imageKey=DERM%2F101941\" class=\"graphic graphic_picture graphicRef101941 \">picture 5</a>): The significance of vascular structures and patterns is dependent on the morphology of the lesion (ie, flat versus raised).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Flat lesions &ndash; For macular lesions, the clinician needs to determine whether the vascular pattern is monomorphous or polymorphous.</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Monomorphous vascular pattern: Lesions displaying a monomorphous vascular pattern other than clods-only (lacunae) should be considered suspicious (eg, monomorphous serpentine vessels in BCC, monomorphous coiled vessels in SCC, monomorphic dotted vessels in melanoma).</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Polymorphous vascular pattern: Lesions revealing this pattern should be considered suspicious.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Raised lesions &ndash; Lesions displaying only clods (lacunae) are considered benign angiomas. For all other palpable lesions, the observer needs to determine the vessel arrangement.</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Radial (eg, SCC, keratoacanthoma, ulcerated BCC, sebaceous hyperplasia, molluscum contagiosum).</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Branched (eg, BCC, SCC, keratoacanthoma, cysts).</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Serpiginous (eg, clear cell acanthoma).</p><p/><p class=\"bulletIndent3\"><span class=\"glyph\">&#45;</span>Centered (eg, papillomatous intradermal nevi, seborrheic keratosis).</p><p/><p>In raised lesions, blood vessel patterns other than those described above are considered nonspecific. Lesions with nonspecific vessel arrangement should be biopsied to rule out malignancy.</p><p class=\"headingAnchor\" id=\"H1060806122\"><span class=\"h3\">Limitations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The &quot;prediction without pigment&quot; algorithm was designed only for the evaluation of nonpigmented lesions and cannot be used for evaluating pigmented or hypopigmented lesions. In addition, it is quite complex and may not be ideal as a triage tool.</p><p class=\"headingAnchor\" id=\"H1060806128\"><span class=\"h1\">TRIAGE AMALGAMATED DERMOSCOPY ALGORITHM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Based on the strengths and limitations of the aforementioned triage algorithms, the authors designed a relatively simple two-step algorithm with the aim of guiding the health provider's management decision in a skin cancer triage setting [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/21,22\" class=\"abstract_t\">21,22</a>]. The &quot;triage amalgamated dermoscopic algorithm&quot; (TADA) (<a href=\"image.htm?imageKey=DERM%2F101944\" class=\"graphic graphic_algorithm graphicRef101944 \">algorithm 3</a>) integrates key criteria suggesting malignancy derived from existing algorithms for pigmented and nonpigmented lesions (see <a href=\"#H1060806034\" class=\"local\">'Algorithms for pigmented lesions'</a> above and <a href=\"#H1060806096\" class=\"local\">'Algorithms for nonpigmented lesions'</a> above):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asymmetric distribution of colors and structures or starburst-like pattern</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Blue-black or gray color</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>White structures including negative network</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ulceration (without a history of trauma) or vascular structures</p><p/><p>This algorithm is relatively simple and easy to use, requires minimal training, and can guide the management of suspicious skin lesions in a skin cancer triage setting (<a href=\"image.htm?imageKey=DERM%2F101945%7EDERM%2F101946\" class=\"graphic graphic_picture graphicRef101945 graphicRef101946 \">picture 6A-B</a>). The sensitivity and specificity of the TADA algorithm used by clinicians and nurse practitioners were approximately 95 and 72 percent, respectively [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/21,22\" class=\"abstract_t\">21,22</a>]. </p><p>The use of TADA involves the following steps:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Step 1</strong> &ndash; In the first step, the clinician determines first whether a lesion is one of the most common benign lesions encountered in clinical practice (ie, unequivocal seborrheic keratosis, angioma, or dermatofibroma) (<a href=\"image.htm?imageKey=DERM%2F101944\" class=\"graphic graphic_algorithm graphicRef101944 \">algorithm 3</a>). Experienced clinicians can also recognize other benign lesions with unequivocal dermoscopic patterns, such as sebaceous hyperplasia, clear cell acanthoma, or intradermal nevus. If the lesion is an obvious benign lesion, the patient can be reassured and no further evaluation is required. </p><p/><p class=\"bulletIndent1\">Despite the fact that some seborrheic keratosis, angiomas, and dermatofibromas may reveal suspicious dermoscopic features such as asymmetry [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/23\" class=\"abstract_t\">23</a>], most can be correctly diagnosed based upon their overall clinical and dermoscopic patterns. It is important to recognize these benign lesions and exclude them from further evaluation to avoid unnecessary biopsies. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Step 2 </strong>&ndash;<strong> </strong>In the second step, lesions that are not identified as unequivocally benign are examined for dermoscopic features that are associated with malignancy. Any isolated neoplasm should be considered suspect if it reveals a disorganized or asymmetric pattern (<a href=\"image.htm?imageKey=DERM%2F101944\" class=\"graphic graphic_algorithm graphicRef101944 \">algorithm 3</a>). Dermoscopic asymmetry, defined as a disorganized or chaotic distribution of colors and structures (<a href=\"image.htm?imageKey=DERM%2F101945\" class=\"graphic graphic_picture graphicRef101945 \">picture 6A</a>), is the single most important feature that helps discriminate benign from malignant lesions [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/11,24-26\" class=\"abstract_t\">11,24-26</a>]. In addition, asymmetry is a reproducible feature that consistently shows the highest interobserver agreement [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/17,27\" class=\"abstract_t\">17,27</a>]. (See <a href=\"#H1060806042\" class=\"local\">'The three-point checklist'</a> above and <a href=\"#H1060806054\" class=\"local\">'The AC rule'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Step 3</strong> &ndash; Lesions not revealing a disorganized or asymmetric dermoscopic pattern should be evaluated further to rule out the rare occurrence of skin cancers manifesting an organized and symmetric pattern. The following features will help correctly identify these organized-appearing cancers:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Starburst pattern</strong> &ndash; Since some spitzoid melanomas may reveal a starburst pattern and since the management of spitzoid lesions remains controversial, all lesions manifesting an organized and symmetric starburst pattern should be classified as suspicious. (See <a href=\"topic.htm?path=spitzoid-melanocytic-neoplasms-spitz-nevus-and-atypical-spitz-tumors\" class=\"medical medical_review\">&quot;Spitzoid melanocytic neoplasms (Spitz nevus and atypical Spitz tumors)&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Blue-black or gray color</strong> &ndash; The presence of blue-black color has a fairly high sensitivity for nodular melanoma [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/12\" class=\"abstract_t\">12</a>]. Gray color has been demonstrated to be an important clue for skin cancer in the chaos and clues algorithm [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/13\" class=\"abstract_t\">13</a>]. Thus the blue-black or gray color criterion is particularly useful in the diagnosis of symmetric nodular-pigmented melanomas, melanomas with regression, and melanomas occurring in sun-damaged skin, including lentigo maligna and lentigo maligna melanoma (<a href=\"image.htm?imageKey=DERM%2F101946\" class=\"graphic graphic_picture graphicRef101946 \">picture 6B</a>) [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/28,29\" class=\"abstract_t\">28,29</a>]. (See <a href=\"#H1060806066\" class=\"local\">'The blue-black rule'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>White structures</strong> <strong>and negative network</strong> &ndash; White structures include shiny white lines, rosettes, shiny white blotches and strands, and white circles. The first three structures are only visible with polarized light. Negative network is a feature associated with melanomas arising in nevi. Both white structures and negative network have a strong association with malignancy [<a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/30-32\" class=\"abstract_t\">30-32</a>]. However, several benign lesions, including dermatofibromas, lichen planus-like keratosis, and Spitz nevi, may occasionally reveal these structures.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Ulceration </strong>without a history of trauma or <strong>vascular structures</strong> (<a href=\"image.htm?imageKey=DERM%2F101946\" class=\"graphic graphic_picture graphicRef101946 \">picture 6B</a>).</p><p/><p>Lesions that have <strong>at least one</strong> of the above features should be biopsied and sent for histopathologic examination. Lesions that should also be considered suspicious and biopsied include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any acral volar lesion with a parallel ridge pattern (<a href=\"image.htm?imageKey=DERM%2F89397\" class=\"graphic graphic_picture graphicRef89397 \">picture 7</a>), even if symmetrically distributed</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any changing lesion in an adult patient</p><p/><p>If none of the above criteria are present and the lesion is not palpable, it can be dermoscopically monitored over time; usually, short-term monitoring (three months) is appropriate.</p><p class=\"headingAnchor\" id=\"H1060806134\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dermoscopy increases the sensitivity for the diagnosis of melanoma compared with naked-eye examination and improves the recognition of numerous pigmented and nonpigmented skin lesions. (See <a href=\"#H1060806022\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Making a correct management decision (ie, reassurance, referral, or skin biopsy) is the main goal of skin cancer triage. For this purpose, several simple and rapid algorithms are available to clinicians with varying degrees of training in dermoscopy, including the three-point checklist, the AC rule, and chaos and clues. (See <a href=\"#H1060806034\" class=\"local\">'Algorithms for pigmented lesions'</a> above and <a href=\"#H1060806096\" class=\"local\">'Algorithms for nonpigmented lesions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The triage amalgamated dermoscopy algorithm incorporates criteria with high sensitivity and specificity extracted from available algorithms to be used in the setting of skin cancer triage (<a href=\"image.htm?imageKey=DERM%2F101944\" class=\"graphic graphic_algorithm graphicRef101944 \">algorithm 3</a>). (See <a href=\"#H1060806128\" class=\"local\">'Triage amalgamated dermoscopy algorithm'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/1\" class=\"nounderline abstract_t\">Marghoob AA, Swindle LD, Moricz CZ, et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol 2003; 49:777.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/2\" class=\"nounderline abstract_t\">Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/3\" class=\"nounderline abstract_t\">Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001; 2:443.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/4\" class=\"nounderline abstract_t\">Argenziano G, Puig S, Zalaudek I, et al. Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol 2006; 24:1877.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/5\" class=\"nounderline abstract_t\">Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137:1343.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/6\" class=\"nounderline abstract_t\">Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159:669.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/7\" class=\"nounderline abstract_t\">Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3:159.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/8\" class=\"nounderline abstract_t\">Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol 2000; 143:1016.</a></li><li class=\"breakAll\">www.ncbi.nlm.nih.gov/mesh/68014218 (Accessed on April 03, 2015).</li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/10\" class=\"nounderline abstract_t\">Soyer HP, Argenziano G, Zalaudek I, et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology 2004; 208:27.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/11\" class=\"nounderline abstract_t\">Luttrell MJ, Hofmann-Wellenhof R, Fink-Puches R, Soyer HP. The AC Rule for melanoma: a simpler tool for the wider community. J Am Acad Dermatol 2011; 65:1233.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/12\" class=\"nounderline abstract_t\">Argenziano G, Longo C, Cameron A, et al. Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma. Br J Dermatol 2011; 165:1251.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/13\" class=\"nounderline abstract_t\">Rosendahl C, Cameron A, McColl I, Wilkinson D. Dermatoscopy in routine practice - 'chaos and clues'. Aust Fam Physician 2012; 41:482.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/14\" class=\"nounderline abstract_t\">Benvenuto-Andrade C, Dusza SW, Agero AL, et al. Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions. Arch Dermatol 2007; 143:329.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/15\" class=\"nounderline abstract_t\">Wang SQ, Dusza SW, Scope A, et al. Differences in dermoscopic images from nonpolarized dermoscope and polarized dermoscope influence the diagnostic accuracy and confidence level: a pilot study. Dermatol Surg 2008; 34:1389.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/16\" class=\"nounderline abstract_t\">Agero AL, Taliercio S, Dusza SW, et al. Conventional and polarized dermoscopy features of dermatofibroma. Arch Dermatol 2006; 142:1431.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/17\" class=\"nounderline abstract_t\">Zalaudek I, Argenziano G, Soyer HP, et al. Three-point checklist of dermoscopy: an open internet study. Br J Dermatol 2006; 154:431.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/18\" class=\"nounderline abstract_t\">Luttrell MJ, McClenahan P, Hofmann-Wellenhof R, et al. Laypersons' sensitivity for melanoma identification is higher with dermoscopy images than clinical photographs. Br J Dermatol 2012; 167:1037.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/19\" class=\"nounderline abstract_t\">Rosendahl C, Tschandl P, Cameron A, Kittler H. Diagnostic accuracy of dermatoscopy for melanocytic and nonmelanocytic pigmented lesions. J Am Acad Dermatol 2011; 64:1068.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/20\" class=\"nounderline abstract_t\">Rosendahl C, Cameron A, Tschandl P, et al. Prediction without Pigment: a decision algorithm for non-pigmented skin malignancy. Dermatol Pract Concept 2014; 4:59.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/21\" class=\"nounderline abstract_t\">Rogers T, Marino ML, Dusza SW, et al. A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA). J Am Board Fam Med 2016; 29:694.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/22\" class=\"nounderline abstract_t\">Rogers T, Marino M, Dusza SW, et al. Triage amalgamated dermoscopic algorithm (TADA) for skin cancer screening. Dermatol Pract Concept 2017; 7:39.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/23\" class=\"nounderline abstract_t\">Scope A, Benvenuto-Andrade C, Agero AL, Marghoob AA. Nonmelanocytic lesions defying the two-step dermoscopy algorithm. Dermatol Surg 2006; 32:1398.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/24\" class=\"nounderline abstract_t\">Stolz W, Riemann A, Cognetta AB, et al. ABCD rule of dermatoscopy: a new practical method for early recognition of malignant melanoma. Eur J Dermatol 1994; 4:521.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/25\" class=\"nounderline abstract_t\">Emiroglu N, Pelin Cengiz F, Hofmann-Wellenhof R. Dermoscopic and clinical features of trunk melanomas. Postepy Dermatol Alergol 2014; 31:362.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/26\" class=\"nounderline abstract_t\">Seidenari S, Pellacani G, Martella A. Acquired melanocytic lesions and the decision to excise: role of color variegation and distribution as assessed by dermoscopy. Dermatol Surg 2005; 31:184.</a></li><li class=\"breakAll\">Unified Dermoscopy Algorithm study, in progress. Preliminary results.</li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/28\" class=\"nounderline abstract_t\">Braun RP, Gaide O, Oliviero M, et al. The significance of multiple blue-grey dots (granularity) for the dermoscopic diagnosis of melanoma. Br J Dermatol 2007; 157:907.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/29\" class=\"nounderline abstract_t\">Jaimes N, Marghoob AA, Rabinovitz H, et al. Clinical and dermoscopic characteristics of&nbsp;melanomas on nonfacial chronically sun-damaged skin. J Am Acad Dermatol 2015; 72:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/30\" class=\"nounderline abstract_t\">Balagula Y, Braun RP, Rabinovitz HS, et al. The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions. J Am Acad Dermatol 2012; 67:194.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/31\" class=\"nounderline abstract_t\">Liebman TN, Rabinovitz HS, Balagula Y, et al. White shiny structures in melanoma and BCC. Arch Dermatol 2012; 148:146.</a></li><li><a href=\"https://www.uptodate.com/contents/dermoscopic-algorithms-for-skin-cancer-triage/abstract/32\" class=\"nounderline abstract_t\">Pizzichetta MA, Talamini R, Marghoob AA, et al. Negative pigment network: an additional dermoscopic feature for the diagnosis of melanoma. J Am Acad Dermatol 2013; 68:552.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 100084 Version 5.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1060806134\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1060806022\" id=\"outline-link-H1060806022\">INTRODUCTION</a></li><li><a href=\"#H1060806028\" id=\"outline-link-H1060806028\">DERMOSCOPY TECHNIQUES</a></li><li><a href=\"#H1060806034\" id=\"outline-link-H1060806034\">ALGORITHMS FOR PIGMENTED LESIONS</a><ul><li><a href=\"#H1060806042\" id=\"outline-link-H1060806042\">The three-point checklist</a><ul><li><a href=\"#H1060806048\" id=\"outline-link-H1060806048\">- Limitations</a></li></ul></li><li><a href=\"#H1060806054\" id=\"outline-link-H1060806054\">The AC rule</a><ul><li><a href=\"#H1060806060\" id=\"outline-link-H1060806060\">- Limitations</a></li></ul></li><li><a href=\"#H1060806066\" id=\"outline-link-H1060806066\">The blue-black rule</a><ul><li><a href=\"#H1060806072\" id=\"outline-link-H1060806072\">- Limitations</a></li></ul></li><li><a href=\"#H1060806078\" id=\"outline-link-H1060806078\">Chaos and clues</a><ul><li><a href=\"#H1060806090\" id=\"outline-link-H1060806090\">- Limitations</a></li></ul></li></ul></li><li><a href=\"#H1060806096\" id=\"outline-link-H1060806096\">ALGORITHMS FOR NONPIGMENTED LESIONS</a><ul><li><a href=\"#H1060806104\" id=\"outline-link-H1060806104\">Prediction without pigment</a><ul><li><a href=\"#H1060806122\" id=\"outline-link-H1060806122\">- Limitations</a></li></ul></li></ul></li><li><a href=\"#H1060806128\" id=\"outline-link-H1060806128\">TRIAGE AMALGAMATED DERMOSCOPY ALGORITHM</a></li><li><a href=\"#H1060806134\" id=\"outline-link-H1060806134\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/100084|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=DERM/101935\" class=\"graphic graphic_algorithm\">- Chaos and clues dermoscopy algorithm</a></li><li><a href=\"image.htm?imageKey=DERM/101940\" class=\"graphic graphic_algorithm\">- Prediction without pigment algorithm</a></li><li><a href=\"image.htm?imageKey=DERM/101944\" class=\"graphic graphic_algorithm\">- Triage amalgamated dermoscopic algorithm</a></li></ul></li><li><div id=\"DERM/100084|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/71482\" class=\"graphic graphic_figure\">- Dermoscopy colors</a></li><li><a href=\"image.htm?imageKey=DERM/77673\" class=\"graphic graphic_figure\">- Dermoscopic structures 1</a></li><li><a href=\"image.htm?imageKey=DERM/63870\" class=\"graphic graphic_figure\">- Dermoscopic structures 2</a></li><li><a href=\"image.htm?imageKey=DERM/74019\" class=\"graphic graphic_figure\">- Dermoscopic structures 3</a></li><li><a href=\"image.htm?imageKey=DERM/101932\" class=\"graphic graphic_figure\">- Melanoma-specific dermoscopy structures</a></li></ul></li><li><div id=\"DERM/100084|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/101930\" class=\"graphic graphic_picture\">- Dermoscopy three-point checklist melanoma-BCC</a></li><li><a href=\"image.htm?imageKey=DERM/101931\" class=\"graphic graphic_picture\">- Dermoscopy AC rule - melanoma</a></li><li><a href=\"image.htm?imageKey=DERM/101934\" class=\"graphic graphic_picture\">- Dermoscopy blue-black rule BCC</a></li><li><a href=\"image.htm?imageKey=DERM/101938\" class=\"graphic graphic_picture\">- Chaos and clues - BCC and melanoma</a></li><li><a href=\"image.htm?imageKey=DERM/101941\" class=\"graphic graphic_picture\">- Prediction without pigment - melanoma and BCC</a></li><li><a href=\"image.htm?imageKey=DERM/101945\" class=\"graphic graphic_picture\">- TADA algorithm skin cancers</a></li><li><a href=\"image.htm?imageKey=DERM/101946\" class=\"graphic graphic_picture\">- TADA algorithm skin cancers 2</a></li><li><a href=\"image.htm?imageKey=DERM/89397\" class=\"graphic graphic_picture\">- Melanoma parallel ridge pattern</a></li></ul></li><li><div id=\"DERM/100084|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/101922\" class=\"graphic graphic_table\">- Dermoscopy algorithms</a></li><li><a href=\"image.htm?imageKey=DERM/79290\" class=\"graphic graphic_table\">- Vascular structures 1</a></li><li><a href=\"image.htm?imageKey=DERM/56826\" class=\"graphic graphic_table\">- Vascular structures 2</a></li><li><a href=\"image.htm?imageKey=DERM/68025\" class=\"graphic graphic_table\">- Three-point checklist</a></li><li><a href=\"image.htm?imageKey=DERM/101936\" class=\"graphic graphic_table\">- Dermoscopy chaos and clues</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=dermoscopic-evaluation-of-skin-lesions\" class=\"medical medical_review\">Dermoscopic evaluation of skin lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermoscopy-of-facial-lesions\" class=\"medical medical_review\">Dermoscopy of facial lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermoscopy-of-mucosal-lesions\" class=\"medical medical_review\">Dermoscopy of mucosal lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermoscopy-of-nail-pigmentations\" class=\"medical medical_review\">Dermoscopy of nail pigmentations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermoscopy-of-pigmented-lesions-of-the-palms-and-soles\" class=\"medical medical_review\">Dermoscopy of pigmented lesions of the palms and soles</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-dermoscopy\" class=\"medical medical_review\">Overview of dermoscopy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=spitzoid-melanocytic-neoplasms-spitz-nevus-and-atypical-spitz-tumors\" class=\"medical medical_review\">Spitzoid melanocytic neoplasms (Spitz nevus and atypical Spitz tumors)</a></li></ul></div></div>","javascript":null}